2 Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey Correspondence: Nimet Ylmaz, Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey, Email [email protected] Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists are highly effective agents for the treatment of type 2 diabetes and obesity
The right choice, Pratt and Azagury said, depends on a patients degree of obesity, their medical history, and their own goals and preferences
Results: Visible inch loss and contouring appear within 2-4 weeks
Management Of Side Effects: Most side effects are temporary and generally harmless, which resolve on discontinuing the use of OXONEG INJECTION 1